These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 28870220

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Disruption of Epac1 protects the heart from adenylyl cyclase type 5-mediated cardiac dysfunction.
    Cai W, Fujita T, Hidaka Y, Jin H, Suita K, Prajapati R, Liang C, Umemura M, Yokoyama U, Sato M, Okumura S, Ishikawa Y.
    Biochem Biophys Res Commun; 2016 Jun 17; 475(1):1-7. PubMed ID: 27117748
    [Abstract] [Full Text] [Related]

  • 24. Type VI adenylyl cyclase negatively regulates GluN2B-mediated LTD and spatial reversal learning.
    Chang CP, Lee CT, Hou WH, Lin MS, Lai HL, Chien CL, Chang C, Cheng PL, Lien CC, Chern Y.
    Sci Rep; 2016 Mar 02; 6():22529. PubMed ID: 26932446
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The C1 and C2 domains target human type 6 adenylyl cyclase to lipid rafts and caveolae.
    Thangavel M, Liu X, Sun SQ, Kaminsky J, Ostrom RS.
    Cell Signal; 2009 Feb 02; 21(2):301-8. PubMed ID: 19007881
    [Abstract] [Full Text] [Related]

  • 27. Cardiac adenylyl cyclase overexpression precipitates and aggravates age-related myocardial dysfunction.
    Mougenot N, Mika D, Czibik G, Marcos E, Abid S, Houssaini A, Vallin B, Guellich A, Mehel H, Sawaki D, Vandecasteele G, Fischmeister R, Hajjar RJ, Dubois-Randé JL, Limon I, Adnot S, Derumeaux G, Lipskaia L.
    Cardiovasc Res; 2019 Oct 01; 115(12):1778-1790. PubMed ID: 30605506
    [Abstract] [Full Text] [Related]

  • 28. Differential regulation of vascular tone and remodeling via stimulation of type 2 and type 6 adenylyl cyclases in the ductus arteriosus.
    Yokoyama U, Minamisawa S, Katayama A, Tang T, Suzuki S, Iwatsubo K, Iwasaki S, Kurotani R, Okumura S, Sato M, Yokota S, Hammond HK, Ishikawa Y.
    Circ Res; 2010 Jun 25; 106(12):1882-92. PubMed ID: 20431059
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Selective enhancement of beta-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes.
    Ostrom RS, Violin JD, Coleman S, Insel PA.
    Mol Pharmacol; 2000 May 25; 57(5):1075-9. PubMed ID: 10779394
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Adenylyl cyclase subtype-specific compartmentalization: differential regulation of L-type Ca2+ current in ventricular myocytes.
    Timofeyev V, Myers RE, Kim HJ, Woltz RL, Sirish P, Heiserman JP, Li N, Singapuri A, Tang T, Yarov-Yarovoy V, Yamoah EN, Hammond HK, Chiamvimonvat N.
    Circ Res; 2013 Jun 07; 112(12):1567-76. PubMed ID: 23609114
    [Abstract] [Full Text] [Related]

  • 34. Activation of PH-domain leucine-rich protein phosphatase 2 (PHLPP2) by agonist stimulation in cardiac myocytes expressing adenylyl cyclase type 6.
    Gao MH, Miyanohara A, Feramisco JR, Tang T.
    Biochem Biophys Res Commun; 2009 Jun 26; 384(2):193-8. PubMed ID: 19450723
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Activity of Adenylyl Cyclase Type 6 Is Suppressed by Direct Binding of the Cytoskeletal Protein 4.1G.
    Saito M, Cui L, Hirano M, Li G, Yanagisawa T, Sato T, Sukegawa J.
    Mol Pharmacol; 2019 Oct 26; 96(4):441-451. PubMed ID: 31383768
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Adenylyl cyclase 6 mediates the action of cyclic AMP-dependent secretagogues in mouse pancreatic exocrine cells via protein kinase A pathway activation.
    Sabbatini ME, D'Alecy L, Lentz SI, Tang T, Williams JA.
    J Physiol; 2013 Aug 01; 591(15):3693-707. PubMed ID: 23753526
    [Abstract] [Full Text] [Related]

  • 40. Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase.
    Iwatsubo K, Bravo C, Uechi M, Baljinnyam E, Nakamura T, Umemura M, Lai L, Gao S, Yan L, Zhao X, Park M, Qiu H, Okumura S, Iwatsubo M, Vatner DE, Vatner SF, Ishikawa Y.
    Am J Physiol Heart Circ Physiol; 2012 Jun 15; 302(12):H2622-8. PubMed ID: 22505646
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.